Vectors Research Management’s Usana Health Sciences USNA Stock Holding History

Vectors Research Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300	Closed	-$22K	–	458
2022 Q2	$22K	Hold	300	–	–	0.01%	280
2022 Q1	$24K	Hold	300	–	–	0.01%	276
2021 Q4	$30K	Hold	300	–	–	0.01%	304
2021 Q3	$28K	Hold	300	–	–	0.01%	281
2021 Q2	$31K	Hold	300	–	–	0.01%	276
2021 Q1	$29K	Hold	300	–	–	0.01%	256
2020 Q4	$23K	Hold	300	–	–	0.01%	255
2020 Q3	$22K	Hold	300	–	–	0.01%	237
2020 Q2	$22K	Hold	300	–	–	0.01%	227
2020 Q1	$17K	Sell	300 -300	-50%	-$20.9K	0.01%	247
2019 Q4	$47K	Hold	600	–	–	0.02%	187
2019 Q3	$41K	Hold	600	–	–	0.02%	184
2019 Q2	$48K	Hold	600	–	–	0.03%	164
2019 Q1	$50K	Hold	600	–	–	0.03%	163
2018 Q4	$71K	Hold	600	–	–	0.03%	162
2018 Q3	$69K	Buy	+600	New	+$74.5K	0.04%	160

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vectors Research Management's USNA Position: Q3 2022 in Review

Vectors Research Management sold out of Usana Health Sciences (USNA) in Q3 2022, closing a stake of 300 shares — an estimated $22K sold.

Vectors Research Management first reported a position in USNA in Q3 2018 and held it in 16 quarters. The position peaked at $71K in Q4 2018. 172 funds tracked by Wall St. Rank hold USNA as of Q3 2022.

Vectors Research Management reported no remaining Usana Health Sciences position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 300 Usana Health Sciences shares in Q3 2022, an estimated $22K.
Vectors Research Management first reported a position in Usana Health Sciences in Q3 2018 and held it in 16 quarters.
Vectors Research Management's Usana Health Sciences position peaked at $71K in Q4 2018.
172 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.